English | Español

Technology/Innovation
+ Technology/Innovation
Press release submission | Mar 30, 2019

BIOLINERX LTD.: Announces Successful Engraftment Data From Phase 3 GENESIS Trial for BL-8040 in Multiple Myeloma Patients
+ Community
Press release submission | Mar 22, 2019

LOOPBACK ANALYTICS: Loopback Analytics and The University of Vermont Medical Center Partner on Specialty Pharmacy to Improve Patient Outcomes
+ Technology/Innovation
Press release submission | Mar 20, 2019

INNOVENT BIOLOGICS, INC. : Announces First Patient Dosed in a Phase IIa Clinical Study of IBI306, an Anti-PCSK9 Monoclonal Antibody
+ Technology/Innovation
Press release submission | Mar 15, 2019

AMGEN, INC.: Announces New Four-Year Outcomes Study To Examine Long-Term Effects Of Repatha® (evolocumab) In High-Risk Cardiovascular Disease (CVD) Patients Without Prior Heart Attack Or Stroke
+ Regulatory
Press release submission | Mar 15, 2019

CORNERSTONE HEALTHCARE GROUP: Announces Two New Partnerships with Home Health Acquisition and Launch of Long-Term Acute Care Joint Venture Hospital
+ Technology/Innovation
Karen Kidd | Mar 11, 2019

New technologies can treat anxiety, depression through at-home brain stimulation
+ Technology/Innovation
Press release submission | Mar 7, 2019

ALLERGAN, PLC: FDA Accepts Supplemental Biologics License Applications (sBLAs) for BOTOX® (onabotulinumtoxinA) for Pediatric Patients with Upper and Lower Limb Spasticity
+ Community
Press release submission | Mar 7, 2019

ARIZONA PAIN TREATMENT CENTERS: APTC and Dr. Nasser Help Patients Affected by the Closure of Laser Spine Institute

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones